Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport vs Botox for Forehead Wrinkles
NCT00959907Phase 4Completed
- Sponsor
- Hexsel Dermatology Clinic
- Start
- May 2005
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in forehead wrinkles (2 arms), sponsored by Hexsel Dermatology Clinic. Primary endpoints: Horizontal Action Halo Diameter at 28 days and Compound Muscle Action Potential (ECMAP) in m. Frontalis at 28 days. Started May 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
forehead wrinkles
Beyond the preview
Go deeper on NCT00959907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959907.